Specialists, former government officials augment litigation and health practices

Global and national law firms bolstered their presence in litigation, health, and intellectual property practices with additions from both the public and private sectors.

Jenner & Block

Former Acting U.S. Solicitor General Ian Heath Gershengorn will join the firm as a partner in its Washington, D.C. office, effective September 1, 2017. Gershengorn will serve as chair of the firm’s Appellate and Supreme Court Practice and will also be a member of its Complex Commercial Litigation Practice, where he will use his experience in regulatory matters to assist clients across multiple industry sectors.

Gershengorn was named Acting Solicitor General of the United States on June 2, 2016, an appointment he held until the end of the Obama administration in January 2017. Prior to that, he was the Principal Deputy Solicitor General. He also supervised the government’s briefing in a range of high-profile cases, including those involving the Affordable Care Act (ACA), Dodd-Frank, election law and redistricting, immigration reform, the Fair Housing Act, Title VII, the Religious Freedom Restoration Act, and same-sex marriage.

WilmerHale

 Brian Boynton has returned to the firm as a partner following his service in the U.S. Department of Justice as counselor to former Attorney General Loretta Lynch. He was involved in coordinating the DoJ’s Civil Division’s defense of high-profile and significant matters before the department, including challenges to the ACA, agency guidance relating to gender identity discrimination and other administrative agency actions.

Boynton will be a member of the firm’s Government and Regulatory Litigation Group and will be based in Washington DC.

Polsinelli

Polsinelli added three new members to the firm’s Intellectual Property Department with focus on biotech and life sciences. Dr. David W. Clough joined as shareholder in Polsinelli’s Chicago office, along with patent attorneys Christopher Cabral, shareholder, and John W. Campbell, associate.

Clough brings more than 25 years of experience to the firm and counsels many sectors of the biotechnology, medical, and pharmaceutical industries. His practice focuses on acquiring and enforcing key intellectual property rights globally. Cabral is experienced with biotech and life science patent prosecution and counseling to clients around the world. Campbell offers an extensive background in bioinformatics, biotechnology, and microbiology research.

Goodwin 

Roger Cohenjoined the firm’s Life Sciences and Private Equity practices as a partner at its New York office. Cohen specializes in representing health care, life sciences and health care IT clients, and investors in such companies, in a wide array of regulatory matters. He has particular expertise in health care fraud and abuse, HIPAA and related privacy and data security issues, Medicare and Medicaid rules and regulations, reimbursement matters, telemedicine, and government investigations and enforcement actions, including litigation under the False Claims Act.

East Coast firms add experienced attorneys and specialists

Three East Coast law firms have added experienced attorneys and specialists to their existing health care and life sciences practice groups, with two welcoming partners to their offices and one adding a former government official to its team.

W. Andrew Gantt III has returned to Venable LLP, the firm where he began his legal career, as a partner and co-chair of the firm’s Healthcare practice. He draws on more than 20 years of legal experience to represent health care and life sciences companies, health plans, providers, and suppliers, along with manufacturers and health care information technology, information services, and digital health companies in corporate and regulatory matters. He also advises investors and other financial groups with respect to regulatory issues related to mergers and acquisitions and other matters. Gantt has received national recognition for providing advice regarding Health Insurance Portability and Accountability Act (HIPAA) (P.L. 104-191) compliance and other data, security, and digital health regulatory issues. Gantt looks forward to his work, noting, “Early on, Venable ignited the passion I have today for my law practice, and whether the Affordable Care Act continues in its current form or sees a dramatic overhaul, change is on the horizon for the healthcare industry.” Gant is based in the Baltimore and Washington D.C. offices, but will spend time in San Francisco.

Goodwin Procter LLP welcomes Catherine McCarty as a partner in the firm’s Technology and Life Sciences Group. An intellectual property (IP) specialist, McCarty focuses on IP relating to pharmaceuticals and general chemistry matters, including small molecule drugs, salt forms, solid forms and chemical processes. McCarty aids life sciences companies in protecting their property and advises organizations that invest in pharmaceutical and life sciences and technologies. She works on a variety of projects, including designing and managing worldwide patent estates on drug candidates. She practices in the firm’s Boston office.

Arent Fox LLP has added former Deputy Under Secretary of Food Safety at the U.S. Department of Agriculture (USDA) Brian Ronholm to its Food, Drug, Medical Device & Agriculture Practice as Senior Director of Regulatory Policy. FDA practice leader James R. Ravitz lauded Ronholm’s addition, noting, “As a former senior agency official, he is in a unique position to advise food industry clients and he solidifies our ability to provide comprehensive counseling on food safety matters before the FDA and USDA.” Concentrating on food safety regulation and policy, Ronholm provides clients with strategic advice on navigating regulatory challenges. Ronholm works in the firm’s D.C. office.